Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial (vol 17, pg 342, 2023)

被引：0

作者：

Witztum, Joseph L. ^{[1
]}

Gaudet, Daniel ^{[2
,3
]}

Arca, Marcello ^{[4
]}

Jones, Alan ^{[5
]}

Soran, Handrean ^{[6
]}

Gouni-Berthold, Ioanna ^{[7
,8
]}

Stroes, Erik S. G. ^{[9
]}

Alexander, Veronica J. ^{[10
]}

Jones, Richard ^{[11
]}

Watts, Lynnetta ^{[10
]}

Xia, Shuting ^{[10
]}

Tsimikas, Sotirios ^{[1
,10
]}

机构：

[1] Univ Calif San Diego, Dept Med, Room 1081,9500 Gilman Dr, La Jolla, CA 92093 USA

[2] Univ Montreal, Community Genom Med Ctr, Dept Med, Lipidol Unit, 930 Jacques Cartier Est, Chicoutimi, PQ G7H 7K9, Canada

[3] ECOGENE 21, 930 Jacques Cartier Est, Chicoutimi, PQ G7H 7K9, Canada

[4] Univ Roma La Sapienza, Dept Translat & Precis Med, Viale Univ 37, I-00185 Rome, Italy

[5] Univ Hosp Birmingham NHS Fdn Trust, Heartlands Hosp, Bordesley Green E, Birmingham B9 5SS, England

[6] Manchester Univ NHS Fdn Trust, Manchester Royal Infirm, Oxford Rd, Manchester M13 9WL, England

[7] Univ Cologne, Fac Med, Ctr Endocrinol Diabet & Prevent Med, Kerpener Str 62, D-50937 Cologne, Germany

[8] Univ Hosp Cologne, Kerpener Str 62, D-50937 Cologne, Germany

[9] Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands

[10] Ionis Pharmaceut, 2855 Gazelle Court, Carlsbad, CA 92010 USA

[11] Akcea Therapeut, St James House,72 Adelaide Rd 2, Dublin D02 Y017, Ireland

来源：

JOURNAL OF CLINICAL LIPIDOLOGY | 2024年 / 18卷 / 03期

关键词：

D O I：

10.1016/j.jacl.2023.09.010

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：e482 / e483

页数：2

共 50 条

[21] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
Banerji, A.
Hao, J.
Yu, M.
Bernstein, J.
Johnston, D.
Riedl, M.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
[22] Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER
Thompson, William R.
Manuel, Ryan
Abbruscato, Anthony
Carr, Jim
Campbell, John
Hornby, Brittany
Vaz, Frederic M.
Vernon, Hilary J.
GENETICS IN MEDICINE, 2024, 26 (07)
[23] Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial
Scheffer, Ingrid E.
Halford, Jonathan J.
Miller, Ian
Nabbout, Rima
Sanchez-Carpintero, Rocio
Shiloh-Malawsky, Yael
Wong, Matthew
Zolnowska, Marta
Checketts, Daniel
Dunayevich, Eduardo
Devinsky, Orrin
EPILEPSIA, 2021, 62 (10) : 2505 - 2517
[24] Long-Term Safety and Efficacy of Voxelotor for Patients with Sickle Cell Disease: Results from an Open-Label Extension of the Phase 3 HOPE Trial
Achebe, Maureen
Hassab, Hoda
Alkindi, Salam
Brown, R. Clark Clark
Telfer, Paul
Biemond, Bart J.
Gordeuk, Victor R.
Lipato, Thokozeni
Tonda, Margaret
Gray, Sarah
Howard, Joanna
BLOOD, 2021, 138
[25] Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet Syndrome: Results of the Open-Label Extension Trial (GWPCARE5)
Devinsky, O.
Nabbout, R.
Miller, I.
Laux, L.
Zolnowska, M.
Wright, S.
Roberts, C.
EPILEPSIA, 2018, 59 : S73 - S73
[26] Long-Term Safety And Efficacy Of Add-On Cannabidiol (CBD) Treatment In Patients With Dravet Syndrome In An Open-Label Extension Trial (GWPCARE5)
Nabbout, R.
Halford, J.
Scheffer, I. E.
Sanchez-Carpintero, R.
Malawsky, Y. Shiloh
Wong, M.
Checketts, D.
VanLandingham, K.
EPILEPSIA, 2019, 60 : 63 - 63
[27] LONG-TERM SAFETY AND EFFICACY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS WITH UNCONTROLLED POS: RESULTS FROM A PHASE III OPEN-LABEL EXTENSION TRIAL
Husain, A.
Faught, E.
Chung, S.
Isojarvi, J.
McShea, C.
Doty, P.
EPILEPSIA, 2011, 52 : 155 - 155
[28] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
Leonardi, Craig
Strober, Bruce
Gottlieb, Alice B.
Elewski, Boni E.
Ortonne, Jean-Paul
van de Kerkhof, Peter
Chiou, Chiun-Fang
Dunn, Meleana
Jahreis, Angelika
JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
[29] Long-term Safety and Efficacy of Cannabidiol (CBD) in Patients with Lennox-Gastaut Syndrome (LGS): Results from Open-label Extension Trial (GWPCARE5)
Halford, Jonathan
Marsh, Eric
Mazurkiewicz-Beldzinska, Maria
Gunning, Boudewjin
Checketts, Daniel
Roberts, Claire
Thiele, Elizabeth
NEUROLOGY, 2018, 90
[30] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
Cohen, Stanley
Pablos, Jose L.
Pavelka, Karel
Mueller, Gerard Anton
Matsumoto, Alan
Kivitz, Alan
Wang, Hui
Krishnan, Eswar
ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)

← 1 2 3 4 5 →